Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Diet

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44343   clinical trials with a EudraCT protocol, of which   7372   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  Next»
    Study title: Sweetman-L, Surh-L, Baker-H, Peterson-R-M, Nyhan-W-L. Clinical and metabolic abnormalities in a boy with dietary deficiency of biotin. Pediatrics, {Pediatrics}, Oct 1981, vol. 68, no. 4, p. 553-8, ISSN: 0031-4005.Sweetman-L, Surh-L, Baker-H, Peterson-R-M, Nyhan-W-L. Clinical and metabolic abnormalities in a boy with dietary deficiency of biotin. Pediatrics, {Pediatrics}, Oct 1981, vol. 68, no. 4, p. 553-8, ISSN: 0031-4005.
    Active substance: BIOTIN
    Study summary document link (including results):
    View full study record
    Document reference: 22579
    Study title: Dibba B, Prentice A, Ceesay M, Stirling DM, Cole TJ, Poskitt EM. Effect of calcium supplementation on bone mineral accretion in Gambian children accustomed to a low-calcium diet. Am J Clin Nutr. 2000 Feb; 71(2):544-9. Dibba B, Prentice A, Ceesay M, Stirling DM, Cole TJ, Poskitt EM. Effect of calcium supplementation on bone mineral accretion in Gambian children accustomed to a low-calcium diet. Am J Clin Nutr. 2000 Feb; 71(2):544-9.
    Active substance: CALCIUM CARBONATE
    Study summary document link (including results):
    View full study record
    Document reference: 23158
    Study title: National Academy of Sciences, Institute of Medicine Dietary Reference Intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academy Press: Washington, DC, 1997
    Active substance: CALCIUM COMBINATIONS
    Study summary document link (including results):
    View full study record
    Document reference: 23174
    Study title: (Course of dysentery and the specific alteration of the neutrophils in children in the use of monomycin and a diet with an increased protein content). Techenie dizenterii i spetsificheskaia al'teratsiia neitrofilov krovi u detei v usloviiakh primeneniia monomitsina i diety s povyshennym soderzhaniem belka.Vereshchagin I A, Chernichenko A M. Antibiotiki. 1979 Jul;24(7):532-5. Russian
    Active substance: ERYTHROMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26543
    Study title:
    Active substance: Diclofenac diethylamine
    Study summary document link (including results): 2011-EMA spreadsheet - Voltaren Emulgel - TOPM1.xls
    View full study record
    Document reference: 47910
    Study title:
    Active substance: Diclofenac diethylamine
    Study summary document link (including results): 2011-EMA spreadsheet - Voltaren Emulgel - NGB8855.xls
    View full study record
    Document reference: 47911
    Study title:
    Active substance: Diclofenac diethylamine
    Study summary document link (including results): 2011-EMA spreadsheet - Voltaren Emulgel - NF113.xls
    View full study record
    Document reference: 47912
    Study title:
    Active substance: Diclofenac diethylamine
    Study summary document link (including results): 2011-EMA spreadsheet - Voltaren Emulgel - TOPO1.xls
    View full study record
    Document reference: 47914
    Study title: Study back-ground: Demonstration of efficacy of topically applied Voltaren Emulgel in patients with soft tissue rheumatism
    Active substance: Diclofenac diethylamine
    Study summary document link (including results): 2011-EMA spreadsheet - Voltaren Emulgel - NF112.xls
    View full study record
    Document reference: 47913
    Study title: Tay CL, Tan S. Diclofenac or paracetamol for analgesia in paediatric myringotomy outpatients. Anaesth Intensive Care. 2002 Feb;30(1):55-9.Tay CL, Tan S. Diclofenac or paracetamol for analgesia in paediatric myringotomy outpatients. Anaesth Intensive Care. 2002 Feb;30(1):55-9.
    Active substance: Diclofenac diethylamine
    Study summary document link (including results):
    View full study record
    Document reference: 25966
    Study title: Recommended dietary intakes (RDI) of vitamin C in humans
    Active substance: CHLORPHENAMINE AND FERROUS AND PARACETAMOL
    Study summary document link (including results):
    View full study record
    Document reference: 24031
    Study title: Double-Blind Comparative Studies of Ivermectin, Diethylcarbamazine Citrate and Placebo in Patients with Onchocerciasis.
    Active substance: IVERMECTIN
    Study summary document link (including results): Stromectol_Ivermectin_514_Synopsis.pdf
    View full study record
    Document reference: 30823
    Study title: Nucl Med Commun. 1999 Mar;20(3):255-61. Positron emission tomography using 18F-fluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis. Dietlein M, Krug B, Groth W, Smolarz K, Scheidhauer K, Psaras T, Stützer H, Lackner K, Schicha H.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28185
    Study title: Rofo. 1999 Aug;171(2):87-94. [The lymph node staging of malignant testicular germ-cell tumors] [Article in German] Krug B, Heidenreich A, Dietlein M, Lackner K.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28183
    Study title: Open clinical study in MRI (Magnetic Resonance Imaging) to demonstrate the tolerance and efficacy of Gd-DTPA (Gadolinium Diethylene triamine penta acetic Acid) in the whole body
    Active substance: GADOPENTETIC ACID
    Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_87054_study_synopsis.pdf
    View full study record
    Document reference: 28821
    Study title: .Hampl JS, Betts NM, Benes BA. The "age+5" rule: comparasion of dietery fiber intake among 4- to 10-year-old children. J Am Diet Assoc. 1998 Dec; 98(12):1418-23.
    Active substance: Ispaghula seed
    Study summary document link (including results):
    View full study record
    Document reference: 40033
    Study title: Leis R, Pavon P, Queiro T, Recarey D, Tojo R. Atherogenic diet and blood lipidprofile in children and adolescents from Galicia, NW Spain. The Galinut Study. Acta Paediatr. 1999 Jan; 88(1):19-23.
    Active substance: Ispaghula seed
    Study summary document link (including results):
    View full study record
    Document reference: 21224
    Study title: Leis R, Pavon P, Queiro T, Recarey D, Tojo R. Atherogenic diet and blood lipidprofile in children and adolescents from Galicia, NW Spain. The Galinut Study. Acta Paediatr. 1999 Jan; 88(1):19-23.
    Active substance: Ispaghula seed
    Study summary document link (including results):
    View full study record
    Document reference: 40034
    Study title: Saldanha LG. Fiber in the diet of US children: results of national surveys. Paediatrics. 1995 Nov; 96 (5 Pt 2): 994-7.
    Active substance: Ispaghula seed
    Study summary document link (including results):
    View full study record
    Document reference: 40035
    Study title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Cholesterol-Lowering Efficacy and Safety of Simvastatin as an Adjunct to Diet in Children and Adolescents With Familial Hypercholesterolemia
    Active substance: SIMVASTATIN
    Study summary document link (including results):
    View full study record
    Document reference: 42224
    1  2  Next»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon Jun 16 04:31:04 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA